Extreme Creatine Phosphokinase Elevation in a 20-Year-Old Man Participating in a Clinical Trial of Major Depressive Disorder
J Clin Psychiatry 2008;69(11):1832-1834 [letter]
© Copyright 2015 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.
Sir: Creatine phosphokinase (CPK) is an enzyme primarily
found in cardiac and skeletal muscle as well as in brain tissue
and the gastrointestinal tract. More specifically, CPK is involved
in the conversion of adenosine triphosphate and creatine
to adenosine diphosphate and creatine phosphate via the transfer
of a high-energy phosphate. Minor elevations of CPK occur
routinely with strenuous exercise, hypothyroidism, and statinassociated